FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896586240> ?p ?o ?g. }

• W2896586240 abstract "Background: Dementia has a significant impact on quality of life of older individuals. Impaired proteostasis has been implicated as a potential cause of dementia, that can be therapeutically targeted to improve patient outcomes. This review aimed to collate all current evidence of the potential for targeting proteostasis with repurposed drugs as an intervention for age-related dementia and cognitive decline. Methods: PubMed, Web of Science and Embase databases were searched from inception until 4th July 2017 for studies published in English. Interventional studies of repurposed proteostasis-modifying drugs in Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy Body disease, vascular dementia and cognitive aging, in either animal models or humans with change in cognition as the outcome were included. The SYRCLE and Cochrane tools were used to assess risk of bias for included studies. Results: Overall 47 trials, 38 animal and 9 human, were isolated for inclusion in this review. Drugs tested in animals and humans included lithium, rapamycin, rifampicin, and tyrosine kinase inhibitors. Drugs tested only in animals included Macrophage and Granulocyte-Macrophage Colony Stimulating Factors, methylene blue, dantrolene, geranylgeranylacetone, minocycline and phenylbutyric acid. Lithium (n=10 animal, n=6 human) and rapamycin (n=12 animal, n=1 human) were the most studied proteostasis modifying drugs influencing cognition. Nine of ten animal studies of lithium showed a statistically significant benefit in Alzheimer’s models. Rapamycin demonstrated a significant benefit in models of vascular dementia, aging, and Alzheimer’s, but may not be effective in treating established Alzheimer’s pathology. Lithium and nilotinib had positive outcomes in human studies including Alzheimer’s and Parkinson’s patients respectively, while a human study of rifampicin in Alzheimer’s failed to demonstrate benefit. Microdose lithium showed a strongly significant benefit in both animals and humans. While the risk of bias was relatively low in human studies, the risk of bias in animal studies was largely unclear. Conclusion: Overall, the collective findings support the hypothesis that targeting proteostasis for treatment of dementia may be beneficial, and therefore future studies in humans with repurposed proteostasis modifying drugs are warranted. Larger human clinical trials focusing on safety, efficacy, tolerability and reproducibility are required to translate these therapeutics into clinical practice." @default.
• W2896586240 created "2018-10-26" @default.
• W2896586240 creator A5015665688 @default.
• W2896586240 creator A5018759010 @default.
• W2896586240 creator A5031807724 @default.
• W2896586240 creator A5091239647 @default.
• W2896586240 date "2018-10-30" @default.
• W2896586240 modified "2023-09-25" @default.
• W2896586240 title "Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review" @default.
• W2896586240 cites W1485243151 @default.
• W2896586240 cites W1541192889 @default.
• W2896586240 cites W1836722617 @default.
• W2896586240 cites W1883048423 @default.
• W2896586240 cites W1946583083 @default.
• W2896586240 cites W1981420391 @default.
• W2896586240 cites W1985296586 @default.
• W2896586240 cites W1987487278 @default.
• W2896586240 cites W1988337620 @default.
• W2896586240 cites W1996499871 @default.
• W2896586240 cites W2001229756 @default.
• W2896586240 cites W2002079745 @default.
• W2896586240 cites W2002937059 @default.
• W2896586240 cites W2008815076 @default.
• W2896586240 cites W2024879799 @default.
• W2896586240 cites W2025133084 @default.
• W2896586240 cites W2026286016 @default.
• W2896586240 cites W2037053607 @default.
• W2896586240 cites W2037653131 @default.
• W2896586240 cites W2045033696 @default.
• W2896586240 cites W2058571677 @default.
• W2896586240 cites W2059278059 @default.
• W2896586240 cites W2061419556 @default.
• W2896586240 cites W2062686313 @default.
• W2896586240 cites W2065247147 @default.
• W2896586240 cites W2079474890 @default.
• W2896586240 cites W2079835998 @default.
• W2896586240 cites W2086348133 @default.
• W2896586240 cites W2086477221 @default.
• W2896586240 cites W2089936534 @default.
• W2896586240 cites W2091510620 @default.
• W2896586240 cites W2098923148 @default.
• W2896586240 cites W2098985594 @default.
• W2896586240 cites W2103708669 @default.
• W2896586240 cites W2112873594 @default.
• W2896586240 cites W2117724162 @default.
• W2896586240 cites W2126525177 @default.
• W2896586240 cites W2135175236 @default.
• W2896586240 cites W2136433757 @default.
• W2896586240 cites W2142301391 @default.
• W2896586240 cites W2152409987 @default.
• W2896586240 cites W2159671939 @default.
• W2896586240 cites W2173415260 @default.
• W2896586240 cites W2272042925 @default.
• W2896586240 cites W2289353571 @default.
• W2896586240 cites W2319269644 @default.
• W2896586240 cites W2331867328 @default.
• W2896586240 cites W2397965546 @default.
• W2896586240 cites W2400971574 @default.
• W2896586240 cites W2402735831 @default.
• W2896586240 cites W2422981416 @default.
• W2896586240 cites W2462137239 @default.
• W2896586240 cites W2547593615 @default.
• W2896586240 cites W2569810624 @default.
• W2896586240 cites W2588681363 @default.
• W2896586240 cites W2588731179 @default.
• W2896586240 cites W2596329782 @default.
• W2896586240 cites W2596899328 @default.
• W2896586240 cites W2614842428 @default.
• W2896586240 cites W2712309706 @default.
• W2896586240 cites W2739769016 @default.
• W2896586240 cites W2746935314 @default.
• W2896586240 cites W2764096907 @default.
• W2896586240 cites W2765474246 @default.
• W2896586240 cites W2789778893 @default.
• W2896586240 cites W4248590234 @default.
• W2896586240 cites W4322703303 @default.
• W2896586240 doi "https://doi.org/10.3389/fphys.2018.01520" @default.
• W2896586240 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6218672" @default.
• W2896586240 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30425653" @default.
• W2896586240 hasPublicationYear "2018" @default.
• W2896586240 type Work @default.
• W2896586240 sameAs 2896586240 @default.
• W2896586240 citedByCount "12" @default.
• W2896586240 countsByYear W28965862402019 @default.
• W2896586240 countsByYear W28965862402020 @default.
• W2896586240 countsByYear W28965862402021 @default.
• W2896586240 countsByYear W28965862402022 @default.
• W2896586240 countsByYear W28965862402023 @default.
• W2896586240 crossrefType "journal-article" @default.
• W2896586240 hasAuthorship W2896586240A5015665688 @default.
• W2896586240 hasAuthorship W2896586240A5018759010 @default.
• W2896586240 hasAuthorship W2896586240A5031807724 @default.
• W2896586240 hasAuthorship W2896586240A5091239647 @default.
• W2896586240 hasBestOaLocation W28965862401 @default.
• W2896586240 hasConcept C118552586 @default.
• W2896586240 hasConcept C126322002 @default.
• W2896586240 hasConcept C2776036978 @default.
• W2896586240 hasConcept C2778548049 @default.
• W2896586240 hasConcept C2779134260 @default.
• W2896586240 hasConcept C2779483572 @default.

• next